Jiangxi Rimag Anticipates Up to 1,550% Rise in H1 Profit; Shares Jump 15%
MT Newswires Live
Aug 05
Jiangxi Rimag (HKG:2522) said it expects its H1 profit to rise by up to 1,550% year over year, according to a Hong Kong bourse filing Monday.
Shares of the medical imaging company jumped 15% in recent trade.
The company expects to report 14.5 million yuan to 16.5 million yuan in profit for the six months ended June 30, an increase of 1,350% to 1,550% from the 1 million yuan reported a year prior.
Revenue for the period is expected to rise 9% to 16% to 450 million yuan to 480 million yuan, the firm said.
The company's financial results are due by the end of August.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.